Meeting
2022 ASCO Annual Meeting
CT scan versus bioelectrical impedance spectrometry sarcopenia assessment to predict chemotherapy toxicity in early breast cancer.
Authors
Gabriel Aleixo
Cleveland Clinic Foundation, Cleveland, OH
Gabriel Aleixo , Stephanie A. Valente , Wei Wei , Po-Hao Chen , Halle C. F. Moore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 12078)
DOI
10.1200/JCO.2022.40.16_suppl.12078
Abstract #
12078
Poster Bd #
324
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The impact of low muscle mass and strength on chemotherapy toxicity in women with early breast cancer.
First Author: Andree Kurniawan Jr.
Poster
2023 ASCO Annual Meeting
Disease-free survival (DFS) as a surrogate for overall survival (OS) in patients (pts) with HR+/HER2− early breast cancer (EBC): A correlation analysis.
First Author: Michael Untch
Poster
2022 ASCO Annual Meeting
Hair Safe Study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer therapy—A prospective interventional study.
First Author: Christine Brunner
Poster
2021 ASCO Annual Meeting
Phase I trial of acoustic cluster therapy (ACT) with chemotherapy in patients with liver metastases of gastrointestinal origin (ACTIVATE study).
First Author: Udai Banerji